MRI in patients with cardiac devices

Current Cardiology Reports

Volumn 9, Issue 1, 2007, Pages 63-71

  Martin, Edward T ^a   Sandler, David A ^a  

^a Oklahoma Heart Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNULOPLASTY; ARTIFICIAL HEART PACEMAKER; CLINICAL EFFECTIVENESS; CORONARY STENT; DEFIBRILLATOR; DIAGNOSTIC VALUE; DRUG ELUTING STENT; ELECTROCARDIOGRAM; ELECTROMAGNETIC FIELD; HEART ASSIST DEVICE; HEART OUTPUT; HEART PACING; HEART RATE; HEART STIMULATION; HEART VALVE PROSTHESIS; HEART VENTRICLE ARRHYTHMIA; HUMAN; IN VITRO STUDY; MEDICAL RESEARCH; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PROSTHESIS FAILURE; PUBLIC HEALTH; QUESTIONNAIRE; RADIOFREQUENCY; RELIABILITY; REVIEW; RISK ASSESSMENT; TEMPERATURE MEASUREMENT;

ANIMALS; BLOOD VESSEL PROSTHESIS; CLINICAL TRIALS; DEFIBRILLATORS, IMPLANTABLE; HEART DISEASES; HEART VALVE PROSTHESIS; HEART-ASSIST DEVICES; HUMANS; MAGNETIC RESONANCE IMAGING; PACEMAKER, ARTIFICIAL; STENTS;

EID: 34047272090     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-007-0012-y     Document Type: Review

References (78)

1. Kalin R, Stanton MS: Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005, 28:326-328.
2. United States Food and Drug Administration. A Primer on Medical Device Interactions with Magnetic Resonance Imaging Systems. Available at http://www.fda.gov/cdrh/ode/primerf6.html. Accessed October 26, 2006.
3. Society for Testing and Materials (ASTM) International, Designation: F2503-05. Standard Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment. West Conshohocken, PA: ASTM International; 2005.
4. Pavlicek W, Geisinger M, Castle L, et al.: The effects of nuclear magnetic resonance on patients with cardiac pacemakers. Radiology 1983, 174:149-153.
5. Fetter J, Aram G, Holmes D, et al.: The effects of nuclear magnetic resonance imagers on external and implantable pulse generators. Pacing Clin Electrophysiol 1984, 7:720-727.
6. Lauck G, von Smekal A, Wolke S, et al.: Effects of nuclear magnetic resonance imaging on cardiac pacemakers. Pacing Clin Electrophysiol 1995, 18:1549-1555.
7. Luechinger R, Duru F, Zeijlemaker VA, et al.: Pacemaker reed switch behavior in 0.5, 1.5 and 3.0 Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol 2002, 25:1419-1423.
8. Erlebacher JA, Cahill PT, Panizzo F, et al.: Effect of magnetic resonance imaging on DDD pacemakers. Am J Cardiol 1986, 57:437-440.
9. Achenbach S, Moshage W, Diem B, et al.: Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997, 134:467-473.
10. Sommer T, Valhaus C, Lauck G, et al.: MR imaging and cardiac pacemakers: in vitro evaluation and in vivo studies in 51 patients at 1.5 T. Radiology 2000, 215:869-879.
11. Shellock FG, O'Neil MO, Ivans V, et al.: Cardiac pacemakers and implantable cardioverter defibrillators are unaffected by operation of an extremity MR imaging system. Am J Roentgenol 1999, 172:165-170.
12. Holmes DR, Hayes DL, Gray JE, et al.: The effects of magnetic resonance imaging on implantable pulse generators. Pacing Clin Electrophysiol 1986, 9:360-370.
13. Hayes DL, Holmes DR, Gray JE, et al.: Effect of 1.5 Testa nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. J Am Coll Cardiol 1987,10:782-786.
14. Peden CJ, Collins AG, Butson PC, et al.: Induction of microcurrents in critically ill patients in magnetic resonance systems. Crit Care Med 1993, 21:1923-1928.
15. Roguin A, Zviman MM, Meininger GR et al.: Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004, 110:475-482.
16. Luechinger R, Zeijlemaker VA, Pedersen EM et al.: In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 2005, 26:376-383.
17. Nahrendorf M, Hiller KH, Hu K, et al.: Pacing in high field cardiac magnetic resonance imaging. Pacing Clin Electrophysiol 2004, 27:671-674.
18. Valhaus C, Sommer T, Lewalter T, et al.: Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla? Pacing Clin Electrophysiol 2001, 24:489-495.
19. Garcia-Bolao I, Albaladejo V, Benito A, et al.: Magnetic resonance imaging in a patient with a dual-chamber pacemaker. Acta Cardiol 1998, 1:33-35.
20. Sommer T, Naehle CP, Yang A, et al.: Strategy for safe performance of extrathoracic MRI at 1.5 Tesla in the presence of cardiac pacemakers in non-pacemaker dependent patients. Circulation 2006, 114:1285-1292.
21. Goldshear D, Amikam S, Boulos M, et al.: Magnetic resonance imaging for patients with permanent pacemakers: initial clinical experience. IMAJ 2006, 8:91-94.
22. Del Ojo JL, Villalba J, Sanz O, et al.: Is magnetic resonance imaging safe in cardiac pacemaker recipients? Pacing Clin Electrophysiol 2005, 28:274-278.
23. Martin ET, Coman JC, Shellock FG, et al.: Magnetic resonance imaging and cardiac pacemaker safety at 1.5-T. J Am Coll Cardiol 2004, 43:1315-1324.
24. Nazarian S, Roguin A, Zviman MM, et al.: Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 Tesla. Circulation 2006, 114:1277-1284.
25. Gimbel JR, Johnson D, Levine PA, et al.: Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol 1996, 19:913-919.
26. Irnich W, Irnich B, Bartsch C, et al.: Do we need pacemakers resistant to magnetic resonance imaging? Europace 2005, 7:353-365.
27. Fontaine JM, Mohamed FB, Gottlieb C, et al.: Rapid ventricular pacing in a pacemaker patient undergoing magnetic resonance imaging. Pacing Clin Electrophysiol 1998, 21:1336-1339.
28. Luechinger R, Duru F, Scheidegger MB, et al.: Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 2001, 24:199-205.
29. Fiek M, Remp T, Reithmann C, et al.: Complete loss of ICD programmability after magnetic resonance imaging. Pacing Clin Electrophysiol 2004, 27:1002-1004.
30. Anfinsen O, Bernsten RF, Aass H, et al.: Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin Electrophysiol 2002, 25:1400-1402.
31. Sandler DA, Coman JA, Auerbach EG, Martin ET: Magnetic resonance imaging of patients with pacemakers and implantable cardioverter defibrillators in a 1.5-Tesla magnet: a five year experience. Heart Rhythm Society, 27th Annual Scientific Sessions. Boston, MA: May 17-20, 2006.
32. Gimbel JR, Kanal E, Schwartz KM, et al.: Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol 2005, 28:270-273.
33. Murphy KJ, Cohan RH, Ellis JH: MR imaging in patients with epicardial pacemaker wires. AJR Am J Roentgenol 1999, 172:727-728.
34. Hartnell GG, Spence L, Hughes LA, et al.: Safety of MR imaging in patients who have retained metallic materials after cardiac surgery. AJR Am J Roentgenol 1997, 168:1157-1159.
35. Shellock FG, Riedinger MS: Reproducibility and accuracy of using room-temperature vs. ice-temperature injectate for thermodilution cardiac output determination. Heart Lung 1983, 12:175-176.
36. Shellock FG, Morisoli SM: Ex vivo evaluation of ferromagnetism, heating, and artifacts produced by heart valve prostheses exposed to a 1.5-T MR system. J Magn Reson Imaging 1994, 4:756-758.
37. Edwards MB, Taylor KM, Shellock FG: Prosthetic heart valves: evaluation of magnetic field interactions, heating, and artifacts at 1.5 T. J Magn Reson Imaging 2000, 12:363-369.
38. Shellock FG: Prosthetic heart valves and annuloplasty rings: assessment of magnetic field interactions, heating, and artifacts at 1.5 Tesla. J Cardiovasc Magn Reson 2001, 3:317-324.
39. Soulen RL, Budinger TF, Higgins CB: Magnetic resonance imaging of prosthetic heart valves. Radiology 1985, 154:705-707.
40. Edwards MB, Draper ER, Hand JW, et al.: Mechanical testing of human cardiac tissue: some implications for MRI safety. J Cardiovasc Magn Reson 2005, 7:835-840.
41. Pruefer D, Kalden P, Schreiber W, et al.: In vitro investigation of prosthetic heart valves in magnetic resonance imaging: evaluation of potential hazards. J Heart Valve Dis 2001, 10:410-414.
42. Randall PA, Kohman LJ, Scalzetti EM, et al.: Magnetic resonance imaging of prosthetic cardiac valves in vitro and in vivo. Am J Cardiol 1988, 62:973-976.
43. Condon B, Hadley DM: Potential MR hazard to patients with metallic heart valves: the Lenz effect. J Magn Reson Imaging 2000, 12:171-176.
44. Shellock FG: Biomedical implants and devices: assessment of magnetic field interactions with a 3.0-Tesla MR system. J Magn Reson Imaging 2002, 16:721-732.
45. Shellock FG: Reference Manual for Magnetic Resonance Safety, Implants, and Devices: 2006 Edition. Los Angeles: Biomedical Research Publishing Group; 2006.
46. Rajappan K, Melina G, Bellenger NG, et al.: Evaluation of left ventricular function and mass after Medtronic Freestyle versus homograft aortic root replacement using cardiovascular magnetic resonance. J Heart Valve Dis 2002, 11:60-65.
47. Vliegen HW, van Straten A, de Roos A, et al.: Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of Tetralogy of Fallot. Circulation 2002, 106:1703-1707.
48. Khambadkone S, Coats L, Taylor A, et al.: Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005, 112:1189-1197.
49. Scott NA, Pettigrew RI: Absence of movement of coronary stents after placement in a magnetic resonance imaging field. Am J Cardiol 1994, 73:900-901.
50. Friedrich MG, Strohm O, Kivelitz D et al.: Behavior of implantable coronary stents during magnetic resonance imaging. Int J Cardiovasc Intervent 1999, 2:217-222.
51. Shellock FG, Shellock VJ: Metallic stents: evaluation of MR imaging safety. AJR Am J Roentgenol 1999, 173:543-547.
52. Hug J, Nagel E, Bornstedt A, et al.: Coronary arterial stents: safety and artifacts during MR imaging. Radiology 2000, 216:781-787.
53. Shellock FG: Biomedical implants and devices: assessment of magnetic field interactions with a 3.0-Tesla MR system. J Magn Reson Imaging 2002, 16:721-732.
54. Shellock FG, Forder JR: Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3 Tesla. J Cardiovasc Magn Reson 2005, 7:415-419.
55. Shellock FG: MR safety at 3-Tesla: bare metal and drug eluting coronary artery stents. Signals 2005, 53:26-27.
56. Syed MA, Carlson K, Murphy M, et al.: Long-term safety of cariac magnetic resonance imaging in the first few days after bare-metal stent implantation. J Magn Reson Imaging 2006, 24:1056-1061.
57. Patel M, Albert TS, Kandzari DE, et al.: Acute myocardial infarction: Safety of cardiac MR imaging after percutaneous revascularization with stents. Radiology 2006, 240:674-680.
58. Shellock FG, Morisoli SM: Ex vivo evaluation of ferromagnetism and artifacts of cardiac occluders exposed to a 1.5-T MR system. J Magn Reson Imaging 1994, 4:213-215.
59. Bock M, Mohrs OK, Voigtlaender T, et al.: MRI safety aspects and artifacts of atrial septal defect and patent foramen ovale occluders at 1.5 Tesla: a phantom study. Rofo 2006, 178:272-277.
60. Shellock FG, Valencerina S: Septal repair implants: evaluation of magnetic resonance imaging safety at 3 T. Magn Reson Imaging 2005, 23:1021-1025.
61. Shellock FG, Tkach JA, Ruggieri PM, Masaryk TJ: Cardiac pacemakers, ICDs, and loop recorder: evaluation of translational attraction using conventional ("long-bore") and "short-bore" 1.5- and 3.0-Tesla MR systems. J Cardiovasc Magn Reson 2003, 5:387-397.
62. Gimbel JR, Zarghami J, Machado C, Wilkoff BL: Safe scanning, but frequent artifacts mimicking bradycardia and tachycardia during magnetic resonance imaging (MRI) in patients with an implantable loop recorder (ILR). Ann Noninvasive Electrocardiol 2005, 10:404-408.
63. Anfinsen O, Berntsen RF, Aass H, et al.: Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin Electrophysiol 2002, 25:1400-1402.
64. Wollmann C, Grude M, Tombach B, et al.: Safe performance of magnetic resonance imaging on a patient with an ICD. PACE 2005, 28:339-342.
65. Roguin A, Donahue JK, Bomma CS, et al.: Cardiac magnetic resonance imaging in a patient with implantable cardioverter defibrillator. Pacing Clin Electro Physiol 2005, 28:336-338.
66. Gimbel JR, Kanal E, Schwartz KM, et al.: Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). PACE 2005, 28:270-273.
67. Nemec J: Suppression of implantable cardioverter defibrillator therapy during magnetic resonance imaging. J Cardiovasc Electrophys 2006, 17:444-445.
68. Iberer F, Justich E, Stenzl W, et al.: Nuclear magnetic resonance imaging of a patient with implanted transvenous pacemaker. Herz 1987, 7:196-199.
69. Achenbach S, Moshage W, Kuhn I, et al.: Kernspintomagraphie bei einem patienten mit zweikammer-schrittmachersystem. Z Kardiol 1995, 84(Suppl):119.
70. Alagona P, Toole JC, Maniscalco BS, et al.: Nuclear magnetic resonance imaging in a patient with a DDD pacemaker [letter]. PACE 1989, 12:619.
71. Inbar S, Larson J, Burt T, et al.: Case report: nuclear magnetic resonance imaging in a patient with a pacemaker. Am J Med Sci 1993, 3:174-175.
72. Johnson D: Magnetic resonance imaging effects and considerations with permanent cardiac pacemakers [abstract]. PACE 1994, 17(Suppl):772.
73. Sommer T, Lauck G, Schimpf R, et al.: MRI in patients with cardiac pacemakers: in vitro and in vivo evaluation at 0.5 Tesla. Rofo 1998, 168:36-43.
74. Pennell DJ: Cardiac magnetic resonance with a pacemaker in situ: can it be done [abstract]? j Cardiovasc Magn Reson 1999, 1:72.
75. Juratli N, Sparker J, Gimbel JR, et al.: Strategies for the safe performance of magnetic resonance imaging in selected pacemaker patients [abstract]. Circulation 2001, 104:II638-II639.
76. Schmiedel A, Hackenbroch M, Reinke M, et al.: Magnetic resonance imaging of the brain at 1.5 tesla in patients with cardiac pacemakers: can it be done [abstract]? J Cardiovasc Magn Reson 2002, 4:39-40.
77. Maldonado JG, Pereira ME, Albuquerque KR et al.: Magnetic resonance imaging in a patient with a pacemaker. Arquivos Brasileiros de Cardiologia 2005, 84:428-430.
78. Goldsher D, Amikam S, Boulos M, et al.: Magnetic resonance imaging for patients with permanent pacemakers: initial clinical experience. IMAJ 2006, 8:91-94.